Scopus BioPharma Inc.
SCPS
$0.0003
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -68.69% | -64.74% | -98.43% | -91.44% | -81.53% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -73.95% | -68.27% | 9.71% | -74.17% | -5.48% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -70.31% | -65.22% | -95.24% | -89.74% | -75.45% |
|
|
|||||
| Total Current Assets | -70.31% | -65.22% | -95.24% | -89.74% | -75.45% |
| Net Property, Plant & Equipment | -39.29% | -41.18% | -17.86% | -21.88% | -20.00% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -70.26% | -65.20% | -95.21% | -89.69% | -75.43% |
|
|
|||||
| Total Accounts Payable | 71.06% | 154.21% | 51.25% | -38.38% | -59.10% |
| Total Accrued Expenses | 103.71% | 90.48% | 73.31% | 182.29% | 126.48% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -55.00% | -- | -- | -- |
| Total Other Current Liabilities | -- | -55.00% | -- | -- | -- |
| Total Current Liabilities | 104.84% | 81.25% | 78.75% | 164.59% | -38.91% |
|
|
|||||
| Total Current Liabilities | 104.84% | 81.25% | 78.75% | 164.59% | -38.91% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 104.84% | 81.25% | 78.75% | 164.59% | -38.91% |
|
|
|||||
| Common Stock & APIC | 6.35% | 6.41% | 2.15% | 19.68% | 38.16% |
| Retained Earnings | -17.59% | -20.38% | -28.01% | -46.94% | -47.41% |
| Treasury Stock & Other | 302.50% | 78.05% | 55.13% | 99.83% | 99.23% |
| Total Common Equity | -155.57% | -1,209.77% | -263.40% | -406.73% | -86.43% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -155.57% | -1,209.77% | -263.40% | -406.73% | -86.43% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -184.04% | -1,353.60% | -275.79% | -406.73% | -86.43% |
|
|
|||||